Debra Dyer, MD, Chair of the Lung Cancer Screening Steering committee has a conversation with Dr. Patricia Rivera about the importance of biomarker testing for patients with advanced NSCLC.

Debra Dyer, MD, Chair of the Lung Cancer Screening Steering committee has a conversation with Dr. Patricia Rivera about the proposed USPSTF lung cancer screening guidelines.

Debra Dyer, MD, Chair of the Lung Cancer Screening Steering committee has a conversation with Patricia Rivera, MD about the impact COVID-19 has had on lung caner screening programs across the country.

Debra Dyer, MD, Chair of the Lung Cancer Screening Steering committee has a conversation with Dr. Patricia Rivera about disparities in eligibility criteria for, access to, and implementation of lung cancer screening.

Debra Dyer, MD, Chair of the Lung Cancer Screening Steering committee has a conversation with Ron Simmons about the risks related to lung cancer.

Debra Dyer, MD, Chair of the Lung Cancer Screening Steering committee has a conversation with Ron Simmons about the patient perspective of being diagnosed with lung cancer.

Debra Dyer, MD, Chair of the Lung Cancer Screening Steering committee has a conversation with Ron Simmons about the demographics of patients who get screened for lung cancer.

Debra Dyer, MD, Chair of the Lung Cancer Screening Steering committee has a conversation with Ron Simmons about his cancer journey.

Debra Dyer, MD, Chair of the Lung Cancer Screening Steering committee has a conversation with Linda Dowling about lung cancer screening amidst COVID-19 pandemic.

Debra Dyer, MD, Chair of the Lung Cancer Screening Steering committee has a conversation with Linda Dowling about what the patients should know about lung cancer screening.